Predictive markers of response to isotretinoin in female acne

European Journal of Dermatology

Volumn 23, Issue 4, 2013, Pages 478-486

  Preneau, Sophie ^a   Dessinioti, Clio ^b   Nguyen, Jean Michel ^a,c   Katsambas, Andreas ^b   Dreno, Brigitte ^a,c  

^a HÔTEL DIEU   (France)

^b ANDREAS SYGROS HOSPITAL   (Greece)

^c Team 12   (France)

Author keywords

Female acne; Isotretinoin

Indexed keywords

BIOLOGICAL MARKER; ISOTRETINOIN;

ACNE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CORRELATION ANALYSIS; DIET; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG TOLERANCE; DRY EYE; DRY SKIN; ECLA SCALE; EPIDEMIOLOGICAL DATA; EPIDEMIOLOGICAL FACTOR; FACE; FEMALE; FRANCE; GEA GRADING; GREECE; HIGH GLYCEMIC LOAD DIET; HUMAN; MULTICENTER STUDY; ONSET AGE; PREDICTION; PRESCRIPTION; RATING SCALE; SIDE EFFECT; TOBACCO; TRUNK;

ACNE VULGARIS; ADULT; AGE OF ONSET; BODY MASS INDEX; DERMATOLOGIC AGENTS; DIET, CARBOHYDRATE-RESTRICTED; FEMALE; HUMANS; ISOTRETINOIN; SEVERITY OF ILLNESS INDEX; SMOKING; YOUNG ADULT;

EID: 84884407663     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.2033     Document Type: Article

References (29)

1. Preneau S, Dreno B. Female acne - a different subtype of teenager acne? J Eur Acad Dermatol Venereol 2012; 26: 277-282.
2. Williams C, Layton AM. Persistent acne in women: implications for the patients and for therapy. Am J Clin Dermatol 2006;7:281-290.
3. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol 1999; 41: 577-580.
4. Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. B J Dermatol 1997; 136: 66-70.
5. Layton A. The use of isotretinoin in acne. Dermatoendocrinol 2009;1:162-169.
6. Nelson AM, Zhao W, Gilliland AL, et al. Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol 2009; 1:177-187.
7. Nelson AM, Gilliland KL, Cong Z, et al. 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol 2006;126: 2178-2189.
8. Dreno B, Bodokh I, Chivot M, et al. ECLA grading: a system of acne classification for everyday dermatological practice. Ann Derma-tol Venereol 1999; 126: 136-141.
9. Dreno B, Poli F, Pawin H, et al. Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe. J Eur Acad Dermatol Venereol 2011; 25: 43-48.
10. Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984; 10:490-6.
11. Harms M, Masouye I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study. Der-matologica 1986;172: 148-153.
12. Chivot M, Midoun H. Isotretinoin and acne- a study of relapses. Dermatologica 1990; 180: 240-243.
13. Layton AM, Knaggs H, Taylor J, et al. Isotretinoin for acne vulgaris-10years later: a safe and successful treatment. Br J Dermatol 1993; 129:292-296.
14. Lehucher-Ceyrac D, Weber-Buisset MJ. Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology 1993;186:123-128.
15. Quereux G, Volteau C, N'Guyen JM, et al. Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology 2006;212:168-176.
16. Bener A, Lestringant GG, Ehlayel MS, et al. Treatment outcome of acne vulgaris with oral isotretinoin. J Coll Physicians Surg Pak 2009; 19:49-51.
17. Goulden V, Clark SM, McGeown C, et al. Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997; 137: 106-108.
18. Hermes B, Praetel C, Henz BM. Medium dose isotretinoin for the treatment of acne. J Eur Acad Dermatol Venereol 1998; 11: 117-121.
19. Strauss JS, Leyden JJ, Lucky AW, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol 2001;45:187-195.
20. Mandekou-Lefaki I, Delli F, Teknetzis A, et al. Low-dose schema of isotretinoin in acne vulgaris. Int J Clin Pharmacol Res 2003; 23: 41-44.
21. Kaymak Y, Ilter N. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne. J Eur Acad Dermatol Venereol 2006; 20: 1256-1260.
22. Amichai B, Shemer A, Grundwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006; 54: 644-646.
23. Akman A, Durusoy C, Senturk M, et al. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res 2007; 299: 467-473.
24. Sardana K, Garg VK, Sehgal VN, et al. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. J Eur Acad Dermatol Venereol 2009; 23: 556-560.
25. Lee JW, Yoo KH, Park KY, et al. Effectiveness of conventional, low dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol 2011; 164:1369-1375.
26. Mehra T, Borelli C, Burgdorf W, et al. Treatment of severe acne with low-dose isotretinoin. Acta Derm Venereol 2012; 92: 247-248.
27. Schmitt JV, Tavares M, Cerci FB. Adult women with acne have a higher risk of elevated triglyceride levels with the use of oral isotretinoin. An Bras Dermatol 2011; 86: 807-810.
28. Di Landro A, Cazzaniga S, Parazzini F, et al. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol 2012;67:1129-1135.
29. Capitanio B, Sinagra JL, Ottaviani M, et al. Acne and smoking. Dermatoendocrinol 2009;1:129-135.